Tag: Covid-19
-
NIH Expands Covid-19 Test Technology Challenge
National Institutes of Health is expanding its challenge competition to make tests for Covid-19 viruses more widely available and return results faster.
-
Oxford Covid-19 Vaccine Trial Invokes Immune Responses
Results from a clinical trial testing a Covid-19 vaccine show the vaccine invokes two types of immune responses without serious adverse effects.
-
Covid-19 Vaccines, Therapies – 20 July 2020
This week, the data show a sharp jump in new Covid-19 therapy projects, with 17 new treatments reported raising the total to 322.
-
Infographic – Univ. Students Hope for Campus Return
A poll by Axios suggests college and university students are ready to return to their campuses, and even postpone partying until the pandemic recedes.
-
Start-Up Developing Coronavirus Antibodies, Raises $50M
A new company is underway creating engineered antibodies to neutralize a range of coronaviruses, not just those causing Covid-19 infections.
-
Coating Deactivates Covid-19 Viruses on Surfaces
A chemical engineering lab developed a coating that when applied to surfaces quickly inactivates viruses responsible for Covid-19 infections.
-
Challenge Seeks Next-Generation Face Mask
A challenge competition with a total purse of $1 million seeks a new type of face mask that people will be eager to wear to protect against infectious diseases.
-
Immune Responses Shown in Covid-19 Nasal Vaccine
An experimental vaccine to prevent Covid-19 infections, given as a nasal spray, produces immune responses in tests with lab mice.
-
Covid-19 Vaccines, Therapies – 13 July 2020
This week’s report shows a marked increase in activity on therapies, while the number of vaccines in development and clinical trials increased only slightly.
-
NIH Opens Covid-19 Clinical Trial Network
National Institutes of Health is organizing a collection of sites for late-stage clinical trials to test Covid-19 vaccines and antibody treatments.